Tonix Pharmaceuticals Enters into Research Collaboration and Exclusive License Agreement with University of Alberta to Develop Novel Horsepox-Based Vaccines\, TNX-1810\, TNX-1820 and TNX-1830\, for the Prevention of COVID-19